Advances in Delaying the Onset of Type 1 Diabetes: What Do You Need to Know Now and in the Future?

Partners: The France Foundation; DocMatter

A deep dive on the immunologic aspects of Type 1 Diabetes (T1D) and how these can be utilized to delay onset of T1D. Topics will include applications of immunologic principles to prevent T1D, the latest advances in screening for T1D, and how to utilize immunotherapies to delay T1D.

Concepts to Practice: The Evolving Landscape of Congenital Adrenal Hyperplasia Management Strategies

Partner: Medscape

Congenital adrenal hyperplasia (CAH) is a group of genetic conditions that adversely affect the adrenal glands, resulting in reduced cortisol synthesis and elevated androgen levels. Unfortunately, many children and adults with CAH commonly experience undesired adverse effects from current glucocorticoid treatments. Emerging treatments are being evaluated for their potential to reduce the burden of glucocorticoid dosing that could greatly improve care and quality of life for patients with CAH. Experts will discuss screening and diagnosis of CAH, including challenges with current glucocorticoid treatment, emerging CAH treatments, and strategies for management of CAH within a comprehensive care team environment.

Controversies in Cushing’s Syndrome/Cushing’s Disease (CS/CD) Diagnosis and Management

Partner: CMM Global

During this program, our expert faculty utilize case based discussions to review the standard of care and current practice for treating patients with Cushing’s Disease. Faculty will review and discuss individualized treatment strategies for both mild and severe hypercortisolism and instruct on best practices for managing patients during periods of high stress or illness.

Expert Updates on the Latest in the Development of Weekly Insulin Formulations

Partner: Clinical Care Options (CCO)

Experts on the frontlines of insulin research and patient care will provide the latest evidence on weekly insulin formulation. Faculty will cover the latest in weekly insulin formulations – including mechanisms, efficacy, and safety as well as addressing the anticipated needs of patients and providers, once these treatments are available.

Addressing Treatment Challenges in Growth Hormone Deficiency with Novel Long-Acting Therapies

Partner: Clinical Care Options (CCO)

Leading experts will provide insight and tools for endocrinology specialists to address the treatment challenges in growth hormone deficiency. Learners will strengthen their knowledge and competency with the diagnosis and management of GHD, including incorporating long-acting growth hormone therapy into the care of adult and pediatric patients. Learners will also be equipped with practical strategies to help patients enhance their adherence to GH therapy, especially for young adults as they transition to adult care.

More Than Weight: Treating Obesity as Part of a Comprehensive Care Approach to Cardiometabolic Disease

Partner: Institute for Medical and Nursing Education (IMNE)

Treating obesity is not just about managing weight. Obesity impacts multiple organ systems, and effective management of obesity as a chronic disease requires treating comorbid conditions. This program takes a unique approach to education. Learners will evaluate interesting cases presented on video from experts in other specialties. Learners will then assess treatment approaches for each case based on evidence from expert presentations and faculty discussions.